ES2130219T3 - Moleculas para una administracion por iontoforesis. - Google Patents
Moleculas para una administracion por iontoforesis.Info
- Publication number
- ES2130219T3 ES2130219T3 ES93300166T ES93300166T ES2130219T3 ES 2130219 T3 ES2130219 T3 ES 2130219T3 ES 93300166 T ES93300166 T ES 93300166T ES 93300166 T ES93300166 T ES 93300166T ES 2130219 T3 ES2130219 T3 ES 2130219T3
- Authority
- ES
- Spain
- Prior art keywords
- less
- approximately
- groups
- amino acids
- iontophoresis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Electrotherapy Devices (AREA)
Abstract
LA INVENCION PRESENTA PEPTIDOS Y PROTEINAS PARA UN SUMINISTRO IONTOFORETICO. DE MANERA ESPECIFICA SE PRESENTAN LOS METODOS PARA EL SUMINISTRO IONTOFORETICO DE GRUPOS DE AMINOACIDOS QUE CONSISTEN EN LA MODIFICACION DE DICHOS GRUPOS DE AMINOACIDOS EN UN PUNTO ISOELECTRICO MENOR DE 4,0 APROXIMADAMENTE O MAYOR DE 7,3 APROXIMADAMENTE CON UNA CARGA ELECTROSTATICA DE MAS O MENOS 1 Y UNIDADES CON GRUPOS DE AMINOACIDOS CON PUNTOS ISOELECTRICOS MENORES DE 4,0 APROXIMADAMENTE O MAYORES DE 7,3 APROXIMADAMENTE CON UNA CARGA ELECTROSTATICA DE MAS O MENOS 1.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82373092A | 1992-01-22 | 1992-01-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2130219T3 true ES2130219T3 (es) | 1999-07-01 |
Family
ID=25239567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93300166T Expired - Lifetime ES2130219T3 (es) | 1992-01-22 | 1993-01-12 | Moleculas para una administracion por iontoforesis. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5494679A (es) |
EP (1) | EP0552878B2 (es) |
JP (1) | JP2506543B2 (es) |
AU (1) | AU665046B2 (es) |
CA (1) | CA2087087C (es) |
DE (1) | DE69323913T2 (es) |
ES (1) | ES2130219T3 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6956032B1 (en) * | 1986-04-18 | 2005-10-18 | Carnegie Mellon University | Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
CA2087087C (en) * | 1992-01-22 | 2000-07-18 | Burton H. Sage, Jr. | Molecules for iontophoretic delivery |
GB9312351D0 (en) * | 1993-06-16 | 1993-07-28 | Ici Plc | Thermal transfer printing dyesheet |
US5843015A (en) * | 1993-12-28 | 1998-12-01 | Becton Dickinson And Company | Molecules for iontophoretic delivery |
US5505715A (en) * | 1994-02-25 | 1996-04-09 | Bristol-Myers Squibb Company | Iontophoretic transdermal delivery of deoxyspergualin compounds |
WO1995028145A1 (en) * | 1994-04-18 | 1995-10-26 | The Procter & Gamble Company | Iontophoretic delivery of bisphosphonates to the alveolar bone |
IT1285405B1 (it) | 1995-06-06 | 1998-06-03 | Alza Corp | Modificazione di farmaci polipeptidici per accrescere il flusso per elettrotrasporto. |
US5747453A (en) | 1995-06-06 | 1998-05-05 | Alza Corporation | Method for increasing the electrotransport flux of polypeptides |
US6385487B1 (en) | 1996-05-08 | 2002-05-07 | Biophoretic Therapeutic Systems, Llc | Methods for electrokinetic delivery of medicaments |
US5676648A (en) | 1996-05-08 | 1997-10-14 | The Aps Organization, Llp | Iontophoretic drug delivery apparatus and method for use |
US6333189B1 (en) | 1996-06-06 | 2001-12-25 | Alza Corporation | Method of making an electrotransport device |
WO1997048444A1 (en) * | 1996-06-19 | 1997-12-24 | Becton Dickinson And Company | Iontophoretic delivery of cell adhesion inhibitors |
EA002819B1 (ru) | 1997-05-14 | 2002-10-31 | Авентис Фармасьютикалз Продактс Инк. | Циклическое пептидное соединение и его применение, бициклопептидное соединение, пептидное соединение и его применение, фармацевтическая композиция |
EP0898962A1 (en) * | 1997-08-28 | 1999-03-03 | Becton, Dickinson and Company | Transdermal patches and methods for inactivating skin proteases |
ATE373957T1 (de) | 1997-10-09 | 2007-10-15 | Univ Emory | Verfahren und vorrichtung zur transdermalen verabreichung von lithium |
ES2230727T3 (es) * | 1997-11-12 | 2005-05-01 | Alza Corporation | Procedimiento de administracion dermal de polipeptidos. |
USRE37796E1 (en) | 1997-12-16 | 2002-07-23 | Biophoretic Therapeutic Systems, Llc | Methods for iontophoretic delivery of antiviral agents |
US6148231A (en) * | 1998-09-15 | 2000-11-14 | Biophoretic Therapeutic Systems, Llc | Iontophoretic drug delivery electrodes and method |
US7127285B2 (en) * | 1999-03-12 | 2006-10-24 | Transport Pharmaceuticals Inc. | Systems and methods for electrokinetic delivery of a substance |
US6792306B2 (en) * | 2000-03-10 | 2004-09-14 | Biophoretic Therapeutic Systems, Llc | Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor |
US6477410B1 (en) | 2000-05-31 | 2002-11-05 | Biophoretic Therapeutic Systems, Llc | Electrokinetic delivery of medicaments |
CH696701A5 (de) * | 2001-12-18 | 2007-10-15 | Hoffmann La Roche | Verfahren zum Testen eines Mittels auf dessen Fähigkeit, die Heparanaseaktivität zu hemmen. |
US20100030100A1 (en) * | 2007-02-06 | 2010-02-04 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle Device For Diagnosis Of Allergy |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5314072B2 (es) * | 1973-09-29 | 1978-05-15 | ||
DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
US4585652A (en) * | 1984-11-19 | 1986-04-29 | Regents Of The University Of Minnesota | Electrochemical controlled release drug delivery system |
US5042975A (en) * | 1986-07-25 | 1991-08-27 | Rutgers, The State University Of New Jersey | Iontotherapeutic device and process and iontotherapeutic unit dose |
US5250022A (en) * | 1990-09-25 | 1993-10-05 | Rutgers, The State University Of New Jersey | Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose |
JPS63102768A (ja) * | 1986-10-20 | 1988-05-07 | 山之内製薬株式会社 | イオントフオレ−シス用の新規プラスタ−構造体 |
AU609769B2 (en) * | 1987-02-10 | 1991-05-09 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of proteins |
US4878892A (en) * | 1987-02-10 | 1989-11-07 | Drug Delivery Systems Inc. | Electrolytic transdermal delivery of polypeptides |
US4940456A (en) * | 1987-02-10 | 1990-07-10 | Dan Sibalis | Electrolytic transdermal delivery of proteins |
US4965343A (en) * | 1988-01-28 | 1990-10-23 | Hoffmann-La Roche Inc. | Method of peptide synthesis |
GB8806893D0 (en) * | 1988-03-23 | 1988-04-27 | Unilever Plc | Cosmetic composition |
EP0429842B1 (en) * | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
IT1244030B (it) * | 1989-12-21 | 1994-06-28 | Elan Corp Plc | Dispostitivo in due parti per la somministrazione controllata di un ingrediente |
JPH04224770A (ja) * | 1990-12-26 | 1992-08-14 | Teijin Ltd | イオントフォレーシス用装置 |
DK10191D0 (da) * | 1991-01-22 | 1991-01-22 | Novo Nordisk As | Hidtil ukendte peptider |
US5203768A (en) * | 1991-07-24 | 1993-04-20 | Alza Corporation | Transdermal delivery device |
CA2087087C (en) * | 1992-01-22 | 2000-07-18 | Burton H. Sage, Jr. | Molecules for iontophoretic delivery |
-
1993
- 1993-01-11 CA CA002087087A patent/CA2087087C/en not_active Expired - Fee Related
- 1993-01-12 ES ES93300166T patent/ES2130219T3/es not_active Expired - Lifetime
- 1993-01-12 EP EP93300166A patent/EP0552878B2/en not_active Expired - Lifetime
- 1993-01-12 DE DE69323913T patent/DE69323913T2/de not_active Expired - Fee Related
- 1993-01-20 AU AU31905/93A patent/AU665046B2/en not_active Ceased
- 1993-01-21 JP JP5008485A patent/JP2506543B2/ja not_active Expired - Fee Related
- 1993-12-28 US US08/174,589 patent/US5494679A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2506543B2 (ja) | 1996-06-12 |
US5494679A (en) | 1996-02-27 |
JPH05345727A (ja) | 1993-12-27 |
CA2087087A1 (en) | 1993-07-23 |
AU665046B2 (en) | 1995-12-14 |
EP0552878B2 (en) | 2002-11-20 |
CA2087087C (en) | 2000-07-18 |
EP0552878A2 (en) | 1993-07-28 |
DE69323913T2 (de) | 1999-10-14 |
AU3190593A (en) | 1993-07-29 |
EP0552878A3 (en) | 1993-08-25 |
DE69323913D1 (de) | 1999-04-22 |
EP0552878B1 (en) | 1999-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2130219T3 (es) | Moleculas para una administracion por iontoforesis. | |
ES2127831T3 (es) | Unidades de expresion multicistronicas y su aplicacion. | |
NO306342B1 (no) | Syntetiske eksitatoriske aminosyrer, farmasöytisk formulering inneholdende slike aminosyrer samt mellomprodukt | |
DK1019073T3 (da) | Apoliprotein A-I agonister og deres anvendelse til at behandle dyslipidæmiske lidelser | |
FI945198A0 (fi) | Farmaseuttiset ja muut annosmuodot | |
DE69900746D1 (de) | Gesteuerte verabreichung von peptiden oder proteinen | |
FI924340A (fi) | Farmaceutiska beredningar | |
ATE333464T1 (de) | Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika | |
DE69831971D1 (de) | Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer | |
ATE288719T1 (de) | Kontrollierte abgabe von pharmazeutika in der vorderen augenkammer | |
ES2179077T3 (es) | Acido glutamico decarboxilasa clonada. | |
ATE402957T1 (de) | Analoge des menschlichen interferon-alpha mit niedriger toxizität | |
ATE246103T1 (de) | Bodenstromversorgung fur ein elektrisches fahrzeug mit erdverbindungsvorrichtung | |
ATE388165T1 (de) | Menschliches cnp-gen und vorläuferprotein | |
ATE211655T1 (de) | Iontophoresematrix | |
SE8803847A0 (sv) | Neuromodulerande peptid | |
DK33790D0 (da) | Elektrotransportklaebemiddel | |
ATE347590T1 (de) | Kurze peptide die die aktivität serine/threonine kinasen modulieren | |
SE9403526D0 (sv) | New Peptides | |
FR2768341B1 (fr) | Composition pharmaceutique placebo lyophilisable destinee a imiter un medicament, notamment a base de proteines ou de polypeptides | |
IT1244496B (it) | Impiego terapeutico dei peptidi della somatostatina. | |
BR9202374A (pt) | Composicao implantavel para a administracao parenteral de uma quantidade essencialmente uniforme e continua de uma proteina,um peptideo ou polipeptideo biologicamente ativos,processo de elevar e manter elevados niveis no sangue de uma proteina,peptideo ou polipeptideo biologicamente ativos e processo para a preparacao da composicao implantavel | |
ES2134474T3 (es) | Peptidos utilizados como agentes terapeuticos para el tratamiento de enfermedades autoinmunitarias. | |
DE68906066D1 (de) | Peptid und dessen salze und antiallergische peptidmittel, welche diese peptide enthalten. | |
DE59606266D1 (de) | Verbesserung der Verträglichkeit von pharmazeutisch wirksamen Beta-Aminosäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 552878 Country of ref document: ES |